APA

Palou J., Pisano F., Sylvester R., Joniau S., Serretta V., Larré S., Di Stasi S., van Rhijn B., Witjes A. J., Grotenhuis A., Colombo R., Briganti A., Babjuk M., Soukup V., Malmstrom P. U., Irani J., Malats N., Baniel J., Mano R., Cai T., Cha E. K., Ardelt P., Varkarakis J., Bartoletti R., Dalbagni G., Shariat S. F., Xylinas E., Karnes R. J. & Gontero P. (20190318). Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought. : World journal of urology.

Chicago

Palou J, Pisano F, Sylvester R, Joniau S, Serretta V, Larré S, Di Stasi S, van Rhijn B, Witjes A J, Grotenhuis A, Colombo R, Briganti A, Babjuk M, Soukup V, Malmstrom P U, Irani J, Malats N, Baniel J, Mano R, Cai T, Cha E K, Ardelt P, Varkarakis J, Bartoletti R, Dalbagni G, Shariat S F, Xylinas E, Karnes R J and Gontero P. 20190318. Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought. : World journal of urology.

Harvard

Palou J., Pisano F., Sylvester R., Joniau S., Serretta V., Larré S., Di Stasi S., van Rhijn B., Witjes A. J., Grotenhuis A., Colombo R., Briganti A., Babjuk M., Soukup V., Malmstrom P. U., Irani J., Malats N., Baniel J., Mano R., Cai T., Cha E. K., Ardelt P., Varkarakis J., Bartoletti R., Dalbagni G., Shariat S. F., Xylinas E., Karnes R. J. and Gontero P. (20190318). Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought. : World journal of urology.

MLA

Palou J, Pisano F, Sylvester R, Joniau S, Serretta V, Larré S, Di Stasi S, van Rhijn B, Witjes A J, Grotenhuis A, Colombo R, Briganti A, Babjuk M, Soukup V, Malmstrom P U, Irani J, Malats N, Baniel J, Mano R, Cai T, Cha E K, Ardelt P, Varkarakis J, Bartoletti R, Dalbagni G, Shariat S F, Xylinas E, Karnes R J and Gontero P. Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought. : World journal of urology. 20190318.